Annual Long Term Debt
$82.01 M
+$74.86 M+1046.66%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual long term debt is $82.01 million, with the most recent change of +$74.86 million (+1046.66%) on December 31, 2023.
- During the last 3 years, AUPH annual long term debt has risen by +$74.39 million (+976.37%).
- AUPH annual long term debt is now at all-time high.
Performance
AUPH Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$71.91 M
+$837.00 K+1.18%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly long term debt is $71.91 million, with the most recent change of +$837.00 thousand (+1.18%) on September 30, 2024.
- Over the past year, AUPH quarterly long term debt has increased by +$837.00 thousand (+1.18%).
- AUPH quarterly long term debt is now -16.62% below its all-time high of $86.24 million, reached on June 30, 2023.
Performance
AUPH Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AUPH Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1046.7% | +1.2% |
| 3 y3 years | +976.4% | +889.1% |
| 5 y5 years | - | +889.1% |
AUPH Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1046.7% | -16.6% | +929.3% |
| 5 y | 5-year | at high | -100.0% | -16.6% | -100.0% |
| alltime | all time | at high | -100.0% | -16.6% | -100.0% |
Aurinia Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $71.91 M(+1.2%) |
| Jun 2024 | - | $71.07 M(-3.7%) |
| Mar 2024 | - | $73.81 M(-10.0%) |
| Dec 2023 | $82.01 M(+1046.7%) | $82.01 M(+3.9%) |
| Sep 2023 | - | $78.91 M(-8.5%) |
| Jun 2023 | - | $86.24 M(+1134.4%) |
| Mar 2023 | - | $6.99 M(-2.3%) |
| Dec 2022 | $7.15 M(-6.9%) | $7.15 M(-1.6%) |
| Sep 2022 | - | $7.27 M(-2.2%) |
| Jun 2022 | - | $7.43 M(-1.7%) |
| Mar 2022 | - | $7.56 M(-1.5%) |
| Dec 2021 | $7.68 M(+0.8%) | $7.68 M(-1.5%) |
| Sep 2021 | - | $7.79 M(-0.4%) |
| Jun 2021 | - | $7.82 M(+0.2%) |
| Mar 2021 | - | $7.81 M(+2.5%) |
| Dec 2020 | $7.62 M(>+9900.0%) | $7.62 M(-8.2%) |
| Sep 2020 | - | $8.30 M(+41.8%) |
| Mar 2020 | - | $5.85 M(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $253.00 K(-12.8%) |
| Jun 2019 | - | $290.00 K(-7.9%) |
| Mar 2019 | - | $315.00 K(+2569.5%) |
| Jun 2012 | - | $11.80 K(-51.0%) |
| Mar 2012 | - | $24.10 K(-31.7%) |
| Dec 2011 | $35.30 K(-99.6%) | $35.30 K(-88.7%) |
| Sep 2010 | - | $313.00 K(+626.2%) |
| Jun 2009 | - | $43.10 K(-97.7%) |
| Mar 2009 | - | $1.89 M(-76.7%) |
| Dec 2008 | $8.13 M(+5095.3%) | $8.13 M(-12.8%) |
| Sep 2008 | - | $9.32 M(-11.1%) |
| Jun 2008 | - | $10.49 M(>+9900.0%) |
| Mar 2008 | - | $40.80 K(-73.9%) |
| Dec 2007 | $156.50 K | $156.50 K(+28.4%) |
| Sep 2007 | - | $121.90 K(-23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $159.70 K(-42.8%) |
| Mar 2007 | - | $279.10 K(-54.4%) |
| Dec 2006 | $612.60 K(-73.8%) | $612.60 K(-41.6%) |
| Sep 2006 | - | $1.05 M(-40.8%) |
| Jun 2006 | - | $1.77 M(-7.2%) |
| Mar 2006 | - | $1.91 M(-18.4%) |
| Dec 2005 | $2.34 M(-32.5%) | $2.34 M(-0.6%) |
| Sep 2005 | - | $2.35 M(-13.8%) |
| Jun 2005 | - | $2.73 M(-14.6%) |
| Mar 2005 | - | $3.20 M(-7.7%) |
| Dec 2004 | $3.47 M(+1355.3%) | $3.47 M(+7.4%) |
| Sep 2004 | - | $3.23 M(+1969.2%) |
| Jun 2004 | - | $156.00 K(-16.5%) |
| Mar 2004 | - | $186.80 K(-21.6%) |
| Dec 2003 | $238.30 K(+84.9%) | $238.30 K(-0.5%) |
| Sep 2003 | - | $239.60 K(-23.0%) |
| Jun 2003 | - | $311.10 K(+176.8%) |
| Mar 2003 | - | $112.40 K(-12.8%) |
| Dec 2002 | $128.90 K(+125.3%) | $128.90 K(-18.8%) |
| Sep 2002 | - | $158.80 K(-21.0%) |
| Jun 2002 | - | $201.10 K(-10.4%) |
| Mar 2002 | - | $224.50 K(+624.2%) |
| Dec 2001 | $57.20 K(-1.4%) | - |
| Aug 2001 | - | $31.00 K(-24.4%) |
| May 2001 | - | $41.00 K(-18.2%) |
| Feb 2001 | - | $50.10 K(-13.6%) |
| Nov 2000 | $58.00 K(-14.6%) | $58.00 K(-21.6%) |
| Aug 2000 | - | $74.00 K(+10.9%) |
| May 2000 | - | $66.70 K(-3.2%) |
| Feb 2000 | - | $68.90 K(+1.5%) |
| Nov 1999 | $67.90 K(+4.3%) | $67.90 K(-49.3%) |
| Aug 1999 | - | $133.80 K(+97.3%) |
| May 1999 | - | $67.80 K(+2.3%) |
| Feb 1999 | - | $66.30 K |
| Nov 1998 | $65.10 K | - |
FAQ
- What is Aurinia Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual long term debt year-on-year change?
- What is Aurinia Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly long term debt year-on-year change?
What is Aurinia Pharmaceuticals annual long term debt?
The current annual long term debt of AUPH is $82.01 M
What is the all time high annual long term debt for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual long term debt is $82.01 M
What is Aurinia Pharmaceuticals annual long term debt year-on-year change?
Over the past year, AUPH annual long term debt has changed by +$74.86 M (+1046.66%)
What is Aurinia Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AUPH is $71.91 M
What is the all time high quarterly long term debt for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly long term debt is $86.24 M
What is Aurinia Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, AUPH quarterly long term debt has changed by +$837.00 K (+1.18%)